Characterization of ANGPT2 mutations associated with primary lymphedema
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Loss-of-function mutations in the TIE2-ligand angiopoietin 2 are associated with primary lymphedema in humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Through our SEC-SAXS model, we discovered the topology of the binding and showed that the first FLD in the asymmetric ANGPT2 dimer (13) binds to the Calf1 domain of α5 integrin, and the second FLD binds TIE2.”
From Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling (2026) · cites this paper as [13]
In the citing paper
“Recent studies have demonstrated that beyond the primary signaling mode through TIE2, ANGPTs can also signal via integrins to modulate vascular responses (13, 21–25).”
From Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling (2026) · cites this paper as [13]
In the citing paper
“Interestingly, the model of the dimeric ANGPT2147–496 in complex with the inactive, half-bent α5β1-integrin and TIE2 ECDs could be created without steric clashes while maintaining the overall geometry and interactions of the existing structures found in this study and previously (13, 16, 54–56) (Figure 8, A and B, and Supplemental Video 2).”
From Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling (2026) · cites this paper as [13]
In the citing paper
“Notably, an ANGPT2 mutation associated with human lymphedema showed reduced α5-integrin binding, inducing lymphatic hyperplasia and dilation in mouse skin (13).”
From Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling (2026) · cites this paper as [13]
Citations
Cites
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Svergun, D., Barberato, C., & Koch, M. H. J. (1995) · Journal of Applied Crystallography · doi:10.1107/s0021889895007047 · Cited by 3,434
Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis
Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N., & Yancopoulos, G. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81813-9 · Cited by 2,847
Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
Holash, J., Maisonpierre, P. C., Compton, D., Boland, P., Alexander, C. R., Zagzag, D., Yancopoulos, G. D., & Wiegand, S. J. (1999) · Science · doi:10.1126/science.284.5422.1994 · Cited by 2,195
Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning
Davis, S., Aldrich, T. H., Jones, P. F., Acheson, A., Compton, D. L., Jain, V., Ryan, T. E., Bruno, J., Radziejewski, C., Maisonpierre, P. C., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81812-7 · Cited by 1,989 · cited 1×
“ANGPT1 is secreted by perivascular cells and acts in a paracrine manner (10, 11).”
BackgroundControl of vascular morphogenesis and homeostasis through the angiopoietin–Tie system
Augustin, H. G., Young Koh, G., Thurston, G., & Alitalo, K. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2639 · Cited by 1,465
Self-citationLymphangiogenesis in development and human disease
Alitalo, K., Tammela, T., & Petrova, T. V. (2005) · Nature · doi:10.1038/nature04480 · Cited by 1,285
Self-citationGale, N. W., Thurston, G., Hackett, S. F., Renard, R., Wang, Q., McClain, J., Martin, C., Witte, C., Witte, M. H., Jackson, D., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00217-4 · Cited by 1,018
Global Rigid Body Modeling of Macromolecular Complexes against Small-Angle Scattering Data
Petoukhov, M. V., & Svergun, D. I. (2005) · Biophysical Journal · doi:10.1529/biophysj.105.064154 · Cited by 899
Vascular Dysmorphogenesis Caused by an Activating Mutation in the Receptor Tyrosine Kinase TIE2
Vikkula, M., Boon, L. M., Iii, K. L. C., Calvert, J. T., Diamonti, A. J., Goumnerov, B., Pasyk, K. A., Marchuk, D. A., Warman, M. L., Cantley, L. C., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81814-0 · Cited by 802
Self-citationFiedler, U., Scharpfenecker, M., Koidl, S., Hegen, A., Grunow, V., Schmidt, J. M., Kriz, W., Thurston, G., & Augustin, H. G. (2004) · Blood · doi:10.1182/blood-2003-10-3685 · Cited by 742
Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema
Karkkainen, M. J., Ferrell, R. E., Lawrence, E. C., Kimak, M. A., Levinson, K. L., McTigue, M. A., Alitalo, K., & Finegold, D. N. (2000) · Nature Genetics · doi:10.1038/75997 · Cited by 650
Self-citationTherapeutic targeting of the angiopoietin–TIE pathway
Saharinen, P., Eklund, L., & Alitalo, K. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.278 · Cited by 620 · cited 1×
“Furthermore, ANGPT2 is selectively expressed in ECs of actively remodeling vessels, for example, in tumors (16), and contributes to endothelial destabilization in inflammation and cancer (17).”
BackgroundSelf-citationLimaye, N., Wouters, V., Uebelhoer, M., Tuominen, M., Wirkkala, R., Mulliken, J. B., Eklund, L., Boon, L. M., & Vikkula, M. (2009) · Nature Genetics · doi:10.1038/ng.272 · Cited by 492
Self-citationAngiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling
Felcht, M., Luck, R., Schering, A., Seidel, P., Srivastava, K., Hu, J., Bartol, A., Kienast, Y., Vettel, C., Loos, E. K., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58832 · Cited by 479
Saharinen, P., Eklund, L., Miettinen, J., Wirkkala, R., Anisimov, A., Winderlich, M., Nottebaum, A., Vestweber, D., Deutsch, U., Koh, G. Y., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1715 · Cited by 471
Self-citationCongenital Hereditary Lymphedema Caused by a Mutation That Inactivates VEGFR3 Tyrosine Kinase
Irrthum, A., Karkkainen, M. J., Devriendt, K., Alitalo, K., & Vikkula, M. (2000) · The American Journal of Human Genetics · doi:10.1086/303019 · Cited by 430
Self-citationFukuhara, S., Sako, K., Minami, T., Noda, K., Kim, H. Z., Kodama, T., Shibuya, M., Takakura, N., Koh, G. Y., & Mochizuki, N. (2008) · Nature Cell Biology · doi:10.1038/ncb1714 · Cited by 387
Self-citationScharpfenecker, M., Fiedler, U., Reiss, Y., & Augustin, H. G. (2005) · Journal of Cell Science · doi:10.1242/jcs.01653 · Cited by 382
Angiopoietin 2 Is a Partial Agonist/Antagonist of Tie2 Signaling in the Endothelium
Yuan, H. T., Khankin, E. V., Karumanchi, S. A., & Parikh, S. M. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01472-08 · Cited by 373
Genetics of lymphatic anomalies
Brouillard, P., Boon, L., & Vikkula, M. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71614 · Cited by 355
Self-citationMutation of the angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema
Bafunno, V., Firinu, D., D'Apolito, M., Cordisco, G., Loffredo, S., Leccese, A., Bova, M., Barca, M. P., Santacroce, R., Cicardi, M., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.05.020 · Cited by 308
Endothelial destabilization by angiopoietin-2 via integrin β1 activation
Hakanpaa, L., Sipila, T., Leppanen, V.-M., Gautam, P., Nurmi, H., Jacquemet, G., Eklund, L., Ivaska, J., Alitalo, K., & Saharinen, P. (2015) · Nature Communications · doi:10.1038/ncomms6962 · Cited by 287
Self-citationTie1 controls angiopoietin function in vascular remodeling and inflammation
Korhonen, E. A., Lampinen, A., Giri, H., Anisimov, A., Kim, M., Allen, B., Fang, S., D’Amico, G., Sipilä, T. J., Lohela, M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84923 · Cited by 283
Self-citationAngiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity
Souma, T., Tompson, S. W., Thomson, B. R., Siggs, O. M., Kizhatil, K., Yamaguchi, S., Feng, L., Limviphuvadh, V., Whisenhunt, K. N., Maurer-Stroh, S., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85830 · Cited by 259
COMP-Ang1: A designed angiopoietin-1 variant with nonleaky angiogenic activity
Cho, C.-H., Kammerer, R. A., Lee, H. J., Steinmetz, M. O., Ryu, Y. S., Lee, S. H., Yasunaga, K., Kim, K.-T., Kim, I., Choi, H.-H., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307574101 · Cited by 257
Self-citationAngiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells
Daly, C., Pasnikowski, E., Burova, E., Wong, V., Aldrich, T. H., Griffiths, J., Ioffe, E., Daly, T. J., Fandl, J. P., Papadopoulos, N., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607538103 · Cited by 251
Blue Rubber Bleb Nevus (BRBN) Syndrome Is Caused by Somatic TEK (TIE2) Mutations
Soblet, J., Kangas, J., Nätynki, M., Mendola, A., Helaers, R., Uebelhoer, M., Kaakinen, M., Cordisco, M., Dompmartin, A., Enjolras, O., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.07.034 · Cited by 251
Self-citationAngiopoietin-1 promotes lymphatic sprouting and hyperplasia
Tammela, T., Saaristo, A., Lohela, M., Morisada, T., Tornberg, J., Norrmén, C., Oike, Y., Pajusola, K., Thurston, G., Suda, T., et al. (2005) · Blood · doi:10.1182/blood-2004-08-3327 · Cited by 236
Self-citationDavis, S., Papadopoulos, N., Aldrich, T. H., Maisonpierre, P. C., Huang, T., Kovac, L., Xu, A., Leidich, R., Radziejewska, E., Rafique, A., et al. (2003) · Nature Structural Biology · doi:10.1038/nsb880 · Cited by 234
GATA2 is required for lymphatic vessel valve development and maintenance
Kazenwadel, J., Betterman, K. L., Chong, C.-E., Stokes, P. H., Lee, Y. K., Secker, G. A., Agalarov, Y., Demir, C. S., Lawrence, D. M., Sutton, D. L., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78888 · Cited by 233
Effects of Angiopoietin-2-Blocking Antibody on Endothelial Cell–Cell Junctions and Lung Metastasis
Holopainen, T., Saharinen, P., D’Amico, G., Lampinen, A., Eklund, L., Sormunen, R., Anisimov, A., Zarkada, G., Lohela, M., Heloterä, H., et al. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs009 · Cited by 216
Self-citationAnalysis of X-ray and neutron scattering from biomacromolecular solutions
Petoukhov, M. V., & Svergun, D. I. (2007) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2007.06.009 · Cited by 215
Defective remodeling and maturation of the lymphatic vasculature in Angiopoietin-2 deficient mice
Dellinger, M., Hunter, R., Bernas, M., Gale, N., Yancopoulos, G., Erickson, R., & Witte, M. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2008.04.024 · Cited by 190
VE-PTP controls blood vessel development by balancing Tie-2 activity
Winderlich, M., Keller, L., Cagna, G., Broermann, A., Kamenyeva, O., Kiefer, F., Deutsch, U., Nottebaum, A. F., & Vestweber, D. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200811159 · Cited by 189
Angiopoietin-1 is required for Schlemm’s canal development in mice and humans
Thomson, B. R., Souma, T., Tompson, S. W., Onay, T., Kizhatil, K., Siggs, O. M., Feng, L., Whisenhunt, K. N., Yanovitch, T. L., Kalaydjieva, L., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci95545 · Cited by 171
Oligomerization and Multimerization Are Critical for Angiopoietin-1 to Bind and Phosphorylate Tie2
Kim, K.-T., Choi, H.-H., Steinmetz, M. O., Maco, B., Kammerer, R. A., Ahn, S. Y., Kim, H.-Z., Lee, G. M., & Koh, G. Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500292200 · Cited by 170
Self-citationContext-dependent functions of angiopoietin 2 are determined by the endothelial phosphatase VEPTP
Souma, T., Thomson, B. R., Heinen, S., Anna Carota, I., Yamaguchi, S., Onay, T., Liu, P., Ghosh, A. K., Li, C., Eremina, V., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714446115 · Cited by 135
Angiopoietin 2 regulates the transformation and integrity of lymphatic endothelial cell junctions
Zheng, W., Nurmi, H., Appak, S., Sabine, A., Bovay, E., Korhonen, E. A., Orsenigo, F., Lohela, M., D’Amico, G., Holopainen, T., et al. (2014) · Genes & Development · doi:10.1101/gad.237677.114 · Cited by 134 · cited 1×
“ANGPT2 LOF mutations in humans may act similarly to the ANGPT2-blocking antibodies previously tested in mouse embryos, by affecting the formation of button-type LEC junctions, adherens junction stability, or lymphatic valve formation and maturation during collecting lymphatic vessel development (20).”
BackgroundSelf-citationStructural basis of Tie2 activation and Tie2/Tie1 heterodimerization
Leppänen, V.-M., Saharinen, P., & Alitalo, K. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616166114 · Cited by 127
Self-citationLoss of ADAMTS3 activity causes Hennekam lymphangiectasia–lymphedema syndrome 3
Brouillard, P., Dupont, L., Helaers, R., Coulie, R., Tiller, G. E., Peeden, J., Colige, A., & Vikkula, M. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx297 · Cited by 127
Self-citationMeyer, N. J., Li, M., Feng, R., Bradfield, J. P., Gallop, R., Bellamy, S. L., Fuchs, B. D., Lanken, P. N., Albelda, S. Μ., Rushefski, M., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201005-0701oc · Cited by 120
Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy
D’Amico, G., Korhonen, E. A., Anisimov, A., Zarkada, G., Holopainen, T., Hägerling, R., Kiefer, F., Eklund, L., Sormunen, R., Elamaa, H., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci68897 · Cited by 95
Self-citationAbnormal embryonic lymphatic vessel development in Tie1 hypomorphic mice
Qu, X., Tompkins, K., Batts, L. E., Puri, M., & Baldwin, H. S. (2010) · Development · doi:10.1242/dev.043380 · Cited by 88
Loss of Endothelial Tie1 Receptor Impairs Lymphatic Vessel Development-Brief Report
D'Amico, G., Korhonen, E. A., Waltari, M., Saharinen, P., Laakkonen, P., & Alitalo, K. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.196618 · Cited by 87
Self-citationAutoTube: a novel software for the automated morphometric analysis of vascular networks in tissues
Zegarra, J. A. M., Russo, E., Runge, P., Jadhav, M., Willrodt, A., Stoma, S., Nørrelykke, S. F., Detmar, M. J., & Halin, C. (2018) · Angiogenesis · doi:10.1007/s10456-018-9652-3 · Cited by 78
Genetic Dissection of Tie Pathway in Mouse Lymphatic Maturation and Valve Development
Shen, B., Shang, Z., Wang, B., Zhang, L., Zhou, F., Li, T., Chu, M., Jiang, H., Wang, Y., Qiao, T., et al. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.302923 · Cited by 69
A collagen IV–derived peptide disrupts α5β1 integrin and potentiates Ang2/Tie2 signaling
Mirando, A. C., Shen, J., Silva, R. L. E., Chu, Z., Sass, N. C., Lorenc, V. E., Green, J. J., Campochiaro, P. A., Popel, A. S., & Pandey, N. B. (2019) · JCI Insight · doi:10.1172/jci.insight.122043 · Cited by 57
Turner, C. J., Badu-Nkansah, K. A., Crowley, D. G., van der Flier, A., & Hynes, R. O. (2014) · Developmental Biology · doi:10.1016/j.ydbio.2014.05.006 · Cited by 46
Tie1 is required for lymphatic valve and collecting vessel development
Qu, X., Zhou, B., & Scott Baldwin, H. (2015) · Developmental Biology · doi:10.1016/j.ydbio.2014.12.021 · Cited by 43
Tie1 regulates the Tie2 agonistic role of angiopoietin-2 in human lymphatic endothelial cells
Song, S.-H., Kim, K. L., Lee, K., & Suh, W. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.02.009 · Cited by 36
Lee, H. S., Oh, S. J., Lee, K.-H., Lee, Y.-S., Ko, E., Kim, K. E., Kim, H.-C., Kim, S., Song, P. H., Kim, Y.-I., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.572594 · Cited by 36
Oh, N., Kim, K., Kim, S. J., Park, I., Lee, J. J., Seo, Y. S., An, H. J., Kim, H. M., & Koh, G. Y. (2015) · Scientific Reports · doi:10.1038/srep15291 · Cited by 34
Self-citationDimerization of Tie2 mediated by its membrane-proximal FNIII domains
Moore, J. O., Lemmon, M. A., & Ferguson, K. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617800114 · Cited by 30 · cited 5×
“Our present SAXS results in combination with the previously published crystal structures and TIE2 clustering schemes (54, 55) allow validation of the N-terminally truncated ANGPT-TIE interactions.”
BackgroundMethodResultInfluentialRole of Angiopoietin-2 in Corneal Lymphangiogenesis
Yuen, D., Grimaldo, S., Sessa, R., Ecoiffier, T., Truong, T. N., Huang, E. C., Bernas, M. J., Daley, S. K., Witte, M. H., & Chen, L. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13779 · Cited by 28
Saharinen, P., Jeltsch, M., Santoyo, M. M., Leppänen, V., & Alitalo, K. K. (2015) · Springer eBooks · doi:10.1007/978-3-319-11888-8_16 · Cited by 21
Self-citationSplice‐site mutations in VEGFC cause loss of function and Nonne‐Milroy‐like primary lymphedema
Fastré, E., Lanteigne, L., Helaers, R., Giacalone, G., Revençu, N., Dionyssiou, D. D., Demiri, E. C., Brouillard, P., & Vikkula, M. (2018) · Clinical Genetics · doi:10.1111/cge.13204 · Cited by 21
Self-citation
Cited by
Lymphatic Malformations: Genetics, Mechanisms and Therapeutic Strategies
Mäkinen, T., Boon, L. M., Vikkula, M., & Alitalo, K. (2021) · Circulation Research · doi:10.1161/circresaha.121.318142 · Cited by 235
Self-citationCurrent Mechanistic Understandings of Lymphedema and Lipedema: Tales of Fluid, Fat, and Fibrosis
Duhon, B. H., Phan, T., Taylor, S. L., Crescenzi, R. L., & Rutkowski, J. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126621 · Cited by 155
Rockson, S. G. (2021) · Circulation Research · doi:10.1161/circresaha.121.318307 · Cited by 152
Lipedema: Insights into Morphology, Pathophysiology, and Challenges
Poojari, A., Dev, K., & Rabiee, A. (2022) · Biomedicines · doi:10.3390/biomedicines10123081 · Cited by 169
Lymphangiogenesis requires Ang2/Tie/PI3K signaling for VEGFR3 cell-surface expression
Korhonen, E. A., Murtomäki, A., Jha, S. K., Anisimov, A., Pink, A., Zhang, Y., Stritt, S., Liaqat, I., Stanczuk, L., Alderfer, L., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci155478 · Cited by 113
“A more profound understanding of Ang2 and Tie1 signaling should be of clinical interest, as Ang2 mutations were already implicated in human primary lymphedema, and Tie1 may follow suit (29, 30).”
BackgroundResultInfluentialSelf-citation
Metadata
- Authors
- Leppänen, V.-M., Brouillard, P., Korhonen, E. A., Sipilä, T., Jha, S. K., Revencu, N., Labarque, V., Fastré, E., Schlögel, M., Ravoet, M., Singer, A., Luzzatto, C., Angelone, D., Crichiutti, G., D’Elia, A., Kuurne, J., Elamaa, H., Koh, G. Y., Saharinen, P., Vikkula, M., & Alitalo, K.
- Affiliations
- University of Helsinki (FI)
- de Duve Institute (BE)
- Wihuri Research Institute (FI)
- Center for Human Genetics, Cliniques universitaires Saint-Luc, University of Louvain, 1200 Brussels, Belgium.
- KU Leuven (BE)
- Cliniques Universitaires Saint-Luc (BE)
- Barzilai Medical Center (IL)
- University of Padua (IT)
- Agostino Gemelli University Polyclinic (IT)
- Ospedale Santa Maria della Misericordia di Udine (IT)
- Azienda Ospedaliero-Universitaria Santa Maria della Misericordia, 33100 Udine, Italy.
- University of Oulu (FI)
- Korea Advanced Institute of Science and Technology (KR)
- ORCID
- Leppänen, Veli-Matti
- Brouillard, Pascal
- Korhonen, Emilia A.
- Sipilä, Tuomas
- Jha, Sawan Kumar
- Revencu, Nicole
- Labarque, Veerle
- Fastré, Elodie
- Schlögel, Matthieu
- Ravoet, Marie
- Luzzatto, Claudia
- Angelone, Donatella
- Crichiutti, Giovanni
- Kuurne, Jaakko
- Elamaa, Harri
- Koh, Gou Young
- Saharinen, Pipsa
- Vikkula, Miikka
- Alitalo, Kari
- Venue
- Science Translational Medicine
- Published
- 2020-09-09
- Volume
- 12
- Issue
- 560
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W3083896784
- Semantic Scholar
- fae5cdf4bce260355df6e94e9bb39525216d5d9e
- Cited by
- 49
- References
- 57
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 11 · 2023: 5 · 2022: 9 · 2021: 11 · 2020: 2
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion, other-oa)
- Työväentutkimus Vuosikirja (submittedVersion)
- Lirias (submittedVersion)
- Funders
- H2020 European Research Council (743155, 773076)
- Fonds De La Recherche Scientifique - FNRS (WELBIO-CR-2015A, FNRS-WELBIO, U.N035.17)
- Fonds pour la Formation à la Recherche dans l’Industrie et dans l’Agriculture
- Academy of Finland (310075, 307366)
- Fund Generet managed by the King Baudouin Foundation
- Topics
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Health Sciences › Medicine › Surgery › Lymphatic Disorders and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- angiopoietin-2, primary lymphedema, loss-of-function mutations, genetic mutations, lymphatic development
- MeSH terms
- Female, Humans, Lymphedema, Mutation, Pregnancy, Signal Transduction, Lymphangiogenesis, Angiopoietin-1, Angiopoietin-2, Endothelial Cells, Receptor, TIE-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.